AestheticsFeatures

Biological Effects of Hyaluronic Acid-Based Dermal Fillers and Laser Therapy on Human Skin Models

By September 23, 2020No Comments

Featured Article

Featured Article

This study investigates the molecular effects of different stabilized HA and poly-l-lactic acid (PLLA)-based fillers with and without subsequent additional fractional laser co-treatment.

Read more

This study investigates the molecular effects of different stabilized HA and poly-l-lactic acid (PLLA)-based fillers with and without subsequent additional fractional laser co-treatment.

Laura Huth PhD, Yvonne Marquardt, Ruth Heise PhD, Katharina Fietkau, Jens Malte Baron MD, Sebastian Huth PhD

 

Injection of hyaluronic acid (HA) dermal fillers is one of the most frequently performed aesthetic procedures. HA fillers exist in many different formulations differing in HA concentration, particle size and cross-linking density.

While HA fillers with high-density and large particles are recommended for deep dermal injections, fillers with low-density and small particles are more commonly used for fine lines.

The direct biological effects of dermal fillers monotherapy and combination therapy with ablative fractional CO2- or Er:YAG laser irradiation on human skin cells are not completely understood. Organotypic three-dimensional (3D) skin equivalents have been established for standardized studies of the human skin.

The aim of the present study was to investigate the molecular effects of different stabilized HA and poly-l-lactic acid (PLLA)-based fillers with and without subsequent additional fractional laser co-treatment.

Read Full Article Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD Article About Looking for Curated Atopic Derm Content? We’ve Got You Covered.

Looking for Curated Atopic Derm Content? We’ve Got You Covered!

| Atopic Dermatitis, Featured Articles, Latest News, The Latest | No Comments
Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on atopic dermatitis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking…
Journal of Drugs in Dermatology JDD Article About Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature

Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature

| Featured Articles, Latest News, The Latest | No Comments
Could Rituximab Be the Key to Managing Epidermolysis Bullosa Acquisita? Epidermolysis bullosa acquisita (EBA) is a rare and often debilitating autoimmune blistering disease that remains notoriously difficult to manage. While…
Journal of Drugs in Dermatology JDD Article About An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over

An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over

| Featured Articles, Latest News, The Latest | No Comments
A Breakthrough Approach to Aging Skin: Can This Cream Combat Dermatoporosis? As skin ages, it becomes fragile, thin, and prone to bruising - a condition known as dermatoporosis, which is…

Leave a Reply